Concepedia

Publication | Open Access

The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial

DOIFull Paper Access

23

Citations

33

References

2021

Year

Mahmoud S. Abdallah, Sumaiah J. Alarfaj, Dalia S. Saif, Mostafa E. El-Naggar, Mohamed Ahmed Elsokary, Hozaifa Elsawah, Shimaa Abdelsattar Zaki, Engy A. Wahsh, Hend E. Abo Mansour, Esraa M. Mosalam
International Immunopharmacology

Abstract

MET improved the anti-rheumatic effect of MTX; suggesting it to be a beneficial adjuvant in patients with RA. Trial registration ID: NCT04068246.

References

YearCitations

Page 1